News Posts List
The political origins of health inequity: prospects for change
02/11/2014
Despite large gains in health over the past few decades, the distribution of health risks worldwide remains extremely and unacceptably uneven.
Survival Outcomes Similar Regardless of Sorafenib-Sunitinib Sequence in mRCC
02/10/2014
The SWITCH trial makes it official: it makes no difference whether patients with metastatic renal cell carcinoma (mRCC) first start on sorafenib and then switch to sunitinib upon progression or vice versa.
Prognostic Tools that Help Make Sense of Localized RCC Heterogeneity, Guide the Decision-Making Process
02/10/2014
One of the greatest challenges clinicians face in treating patients with small renal masses is to make sense of tumor heterogeneity and determine how best to treat these individuals.
Left ventricular infiltration from thyroid papillary carcinoma mimicking the electrocardiographic changes of acute myocardial infarction
02/09/2014
No abstract (ahead of publication)
Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical Management
02/09/2014
Purpose Approximately 5% to 8% of renal cell carcinoma (RCC) is hereditary. No guidelines exist for patient selection for RCC germline mutation testing. We evaluate how age of onset could indicate the need for germline mutation testing for detection of inherited forms of kidney cancer.
Journal of the National Cancer Institute: Investigation of the Obesity Paradox in RCC
02/07/2014
Obesity increases risk for clear-cell renal cell carcinoma, but obese patients appear to experience longer survival than nonobese patients. Why the paradox?
Results of the MARS study in renal cell carcinoma
02/02/2014
Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France
Dr. Primo Lara Presents His Top Five Lists in Renal Cancer Research
02/02/2014
Primo Lara, MD, of the UC Davis Comprehensive Cancer Center, counts down the top five successes and disappointments in the past 20 years of renal cancer research. High on the list of successes: multispecialty coordination in renal cancer research and patient care.
MET variant as a prognostic marker in clear cell renal cell carcinoma
02/02/2014
Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA
The development of squamous cell carcinoma in a patient after kidney transplantation
01/31/2014
In patients with organ transplantation as compared to the general population the risk of cancer is significantly increased.
News Feed